{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T22:54:08Z","timestamp":1720738448308},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":182,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Tianjin Province of China","award":["15JCZDJC35000"],"award-info":[{"award-number":["15JCZDJC35000"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine Case Reports"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.rmcr.2019.100896","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T06:10:58Z","timestamp":1562134258000},"page":"100896","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Blood purification in two patients with clinically amyopathic dermatomyositis associated with interstitial lung disease with anti-melanoma differentiation-associated gene-5 antibody (MDA-5)"],"prefix":"10.1016","volume":"28","author":[{"given":"Han-yu","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-ren","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-qing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-chun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.rmcr.2019.100896_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-014-0465-0","article-title":"Amyopathic dermatomyositis: definitions, diagnosis, and management","volume":"16","author":"Bailey","year":"2014","journal-title":"Curr. Rheumatol. Rep."},{"issue":"5","key":"10.1016\/j.rmcr.2019.100896_bib2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1093\/rheumatology\/ker408","article-title":"Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM\/interstitial lung disease during disease remission","volume":"51","author":"Muro","year":"2012","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rmcr.2019.100896_bib3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bjd.14882","article-title":"Anti-MDA5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis","volume":"176","author":"Matsushita","year":"2016","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.rmcr.2019.100896_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/14397595.2013.852847","article-title":"Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases","volume":"24","author":"Ichiyasu","year":"2014","journal-title":"Mod. Rheumatol."},{"issue":"Suppl. 9","key":"10.1016\/j.rmcr.2019.100896_bib5","first-page":"S102","article-title":"Clinical and immunological associations of autoantibodies to the 140 kDa polypeptide (the US autoantigen) in patients with clinically amyopathic dermatomyositis","volume":"48","author":"Sato","year":"2003","journal-title":"Arthritis & Rheumatology"},{"issue":"5","key":"10.1016\/j.rmcr.2019.100896_bib6","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2014","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.rmcr.2019.100896_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosissup.2012.10.034","article-title":"Immunoadsorption for connective tissue disease","volume":"14","author":"Hohenstein","year":"2013","journal-title":"Atherosclerosis Suppl."},{"issue":"9","key":"10.1016\/j.rmcr.2019.100896_bib8","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s40265-014-0240-6","article-title":"Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment","volume":"74","author":"Hornung","year":"2014","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.rmcr.2019.100896_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.21037\/atm.2017.03.94","article-title":"MDA5 autoantibody\u2014another indicator of clinical diversity in dermatomyositis","volume":"5","author":"Sontheimer","year":"2017","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.rmcr.2019.100896_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfb.2016.03.014","article-title":"Feasibility of using DNA-immobilized nanocellulose-based immunoadsorbent for systemic lupus erythematosus plasmapheresis","volume":"143","author":"Xu","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces"},{"issue":"7","key":"10.1016\/j.rmcr.2019.100896_bib11","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/ard.2004.029660","article-title":"IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study","volume":"64","author":"Stummvoll","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.rmcr.2019.100896_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.autrev.2010.05.020","article-title":"Anti-Ku antibodies: clinical, genetic and diagnostic insights","volume":"9","author":"Belizna","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.rmcr.2019.100896_bib13","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1136\/ard.2006.068502","article-title":"The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis","volume":"66","author":"Chinoy","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.rmcr.2019.100896_bib14","article-title":"Successful multi-target therapy including rituximab and mycophenolate mofetil in anti-melanoma differentiation-associated gene 5 antibody-positive rapidly progressive interstitial lung disease with clinically amyopathic dermatomyositis","volume":"20","author":"Hisanaga","year":"2017","journal-title":"Int. J. Rheumatic Dis."},{"issue":"C","key":"10.1016\/j.rmcr.2019.100896_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rmcr.2016.11.015","article-title":"Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy","volume":"20","author":"Ichiyasu","year":"2017","journal-title":"Respiratory Medicine Case Reports"},{"issue":"1","key":"10.1016\/j.rmcr.2019.100896_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12890-017-0479-2","article-title":"Clinical effects of direct hemoperfusion using a polymyxin B-immobilized fiber column in clinically amyopathic dermatomyositis-associated rapidly progressive interstitial pneumonias","volume":"17","author":"Okabayashi","year":"2017","journal-title":"BMC Pulm. Med."},{"issue":"15","key":"10.1016\/j.rmcr.2019.100896_bib17","article-title":"Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: a case report","volume":"97","author":"Endo","year":"2018","journal-title":"Medicine (Baltim.)"},{"issue":"3","key":"10.1016\/j.rmcr.2019.100896_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2169\/internalmedicine.8335-16","article-title":"The serum ferritin level is associated with the treatment responsivity for rapidly progressive interstitial lung disease with amyopathic dermatomyositis, irrespective of the anti-MDA5 antibody level","volume":"57","author":"Osawa","year":"2018","journal-title":"Internal medicine (Tokyo, Japan)"},{"issue":"6","key":"10.1016\/j.rmcr.2019.100896_bib19","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1378\/chest.13-0186","article-title":"Successful polymyxin B hemoperfusion treatment associated with serial reduction of serum anti-CADM-140\/MDA5 antibody levels in rapidly progressive interstitial lung disease with amyopathic dermatomyositis","volume":"144","author":"Teruya","year":"2013","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.rmcr.2019.100896_bib20","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00393-018-0565-8","article-title":"[Response of dermatomyositis with lung involvement to Janus kinase inhibitor treatment]","volume":"77","author":"Hornig","year":"2018","journal-title":"Zeitschrift fur Rheumatologie"},{"issue":"1","key":"10.1016\/j.rmcr.2019.100896_bib21","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/qjmed\/hcv068","article-title":"Anti-MDA5 dermatomyositis and progressive interstitial pneumonia","volume":"109","author":"Silveira","year":"2016","journal-title":"QJM"},{"issue":"10","key":"10.1016\/j.rmcr.2019.100896_bib22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/1346-8138.13887","article-title":"Clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia: the relation between the disease activity and the serum interleukin-6 level","volume":"44","author":"Yasuda","year":"2017","journal-title":"J. Dermatol."}],"container-title":["Respiratory Medicine Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007119301728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213007119301728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T02:23:51Z","timestamp":1576117431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213007119301728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":22,"alternative-id":["S2213007119301728"],"URL":"https:\/\/doi.org\/10.1016\/j.rmcr.2019.100896","relation":{},"ISSN":["2213-0071"],"issn-type":[{"value":"2213-0071","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood purification in two patients with clinically amyopathic dermatomyositis associated with interstitial lung disease with anti-melanoma differentiation-associated gene-5 antibody (MDA-5)","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmcr.2019.100896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100896"}}